Oral supplements need consistent, long-term use with questionable cost-effectiveness given the temporary results
Thats molecular intervention
Evidence-based weight management recommendations prioritise: Achieving a sustainable calorie deficit through dietary modification (typically 500-600 kcal/day reduction) as recommended by NICE guideline NG246 Increasing physical activity to at least 150 minutes of moderate-intensity exercise weekly, in line with UK Chief Medical Officers' Physical Activity Guidelines Behavioural strategies including self-monitoring, goal-setting, and addressing psychological factors Consideration of NHS weight management services based on local referral criteria, typically for those with BMI 30 kg/m (or 27.5 kg/m for South Asian, Chinese, and other minority ethnic groups) with comorbidities If choosing to trial probiotic supplementation, select products that specify the bacterial strains and colony-forming units (CFUs) on the label
You begin to see weight loss with Wegovy within a few weeks of starting treatment
Search methods for identification of studies Electronic searches A comprehensive search of electronic databases, including PubMed, Scopus, Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library, Web of Science, and Embase, has been performed on 9/9/2024 for articles relating to PD and GLP-1 receptor agonists with keywords that include the following: ((Parkinson) OR (Parkinson*) OR (Parkinson's)) AND ((Glucagon) OR (GLP-1) OR (Glucagon-like peptide-1) OR (Dulaglutide) OR (Exenatide) OR (Liraglutide) OR (Lixisenatide) OR (Semaglutide) OR (Tirzepatide))
Unlike many hypoglycemic drugs, GLP-1 regulates glucose levels in a glucose-dependent manner, significantly reducing the risk of hypoglycemia
